SLGC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SLGC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
SomaLogic's basic earnings per share (Basic EPS) for the three months ended in Sep. 2023 was $-0.12. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.69.
SomaLogic's EPS (Diluted) for the three months ended in Sep. 2023 was $-0.12. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.69.
SomaLogic's EPS without NRI for the three months ended in Sep. 2023 was $-0.10. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2023 was -0.70.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
The historical data trend for SomaLogic's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SomaLogic Annual Data | |||||||
Trend | Dec20 | Dec21 | Dec22 | ||||
EPS (Basic) | -0.29 | -0.64 | -0.59 |
SomaLogic Quarterly Data | |||||||||||||
Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
EPS (Basic) | Get a 7-Day Free Trial | -0.18 | -0.26 | -0.18 | -0.13 | -0.12 |
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
SomaLogic's Basic EPS for the fiscal year that ended in Dec. 2022 is calculated as
Basic EPS (A: Dec. 2022 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Basic Average) |
= | (-109.157 | - | 0) | / | 183.992 | |
= | -0.59 |
SomaLogic's Basic EPS for the quarter that ended in Sep. 2023 is calculated as
Basic EPS (Q: Sep. 2023 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Basic Average) |
= | (-22.157 | - | 0) | / | 187.071 | |
= | -0.12 |
EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.69
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SomaLogic (NAS:SLGC) EPS (Basic) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Thank you for viewing the detailed overview of SomaLogic's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
Alison Marie Roelke | officer: Chief People Officer | 900 INNOVATORS WAY, SIMI VALLEY CA 93065 |
Adam Taich | officer: Interim CEO | C/O SOMALOGIC, INC., 2945 WILDERNESS PLACE, BOULDER CO 80301 |
Ruben Gutierrez | officer: General Counsel | 6435 AVENIDA WILFREDO, LA JOLLA CA 92037 |
Kathy L Hibbs | director | C/O VIROLOGIC, 345 OYSTER POINT BLVD, SOUTH SAN FRANCISCO CA 94080 |
Jason Ryan | director | C/O FOUNDATION MEDICINE, INC., ONE KENDALL SQUARE, SUITE B3501, CAMBRIDGE MA 02139 |
Thomas D. Carey | director | 8 PAIGE STREET, HINGHAM MA 02043 |
Eliot M Lurier | officer: Interim CFO | C/O TENAX THERAPEUTICS, INC., ONE COPLEY PARKWAY, SUITE 490, MORRISVILLE NC 27560 |
Tycho Peterson | director | C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1165 EASTLAKE AVE E, SEATTLE WA 98109 |
Eli Casdin | director | 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019 |
Shaun M. Blakeman | officer: Chief Financial Officer | C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424 |
Anne H. Margulies | director | C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747 |
Richard A Post | director | 998 LACOSTA LANE, LANE TREE CO 80124 |
Charles M. Lillis | director | 13 CASTLE PINES DRIVE N, CASTLE ROCK CO 80108 |
Stephen Quake | director | C/O FLUIDIGM CORPORATION, 7000 SHORELINE COURT, SUITE 100, SOUTH SAN FRANCISCO CA 94080 |
Robert Barchi | director |
From GuruFocus
By PRNewswire • 01-02-2024
By PRNewswire • 10-04-2023
By Business Wire • 12-12-2023
By Marketwired • 09-05-2023
By sperokesalga sperokesalga • 06-06-2023
By sperokesalga sperokesalga • 05-24-2023
By Business Wire • 01-05-2024
By PRNewswire • 12-29-2023
By Marketwired • 07-24-2023
By Marketwired • 10-31-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.